{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:52:11Z","timestamp":1775523131244,"version":"3.50.1"},"reference-count":190,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ncl.2010.03.010","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T09:28:17Z","timestamp":1279272497000},"page":"729-755","source":"Crossref","is-referenced-by-count":20,"title":["Thyroid Eye Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Kimberly P.","family":"Cockerham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2010.03.010_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.80.10.922","article-title":"Thyroid eye disease","volume":"80","author":"Char","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/er.21.2.168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ncl.2010.03.010_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves' ophthalmology","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib4","series-title":"Practical diagnosis and management of orbital disease","first-page":"53","article-title":"Dysthyroid orbitopathy","author":"Kennerdell","year":"2001"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/105072502753600205","article-title":"Psychosocial factors in subjects with thyroid-associated ophthalmopathy","volume":"12","author":"Kahaly","year":"2002","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03345275","article-title":"Effects of Graves' ophthalmopathy on quality of life","volume":"27","author":"Wiersinga","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ncl.2010.03.010_bib7","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Pathophysiology of Graves' ophthalmology: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib8","series-title":"Recent developments in Graves' ophthalmopathy","first-page":"115","article-title":"Radiotherapy for Graves' ophthalmopathy","author":"Kahaly","year":"2000"},{"key":"10.1016\/j.ncl.2010.03.010_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves' ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2010.03.010_bib10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/00006534-200112000-00006","article-title":"Rationale of treatment in Graves' ophthalmopathy","volume":"108","author":"Clauser","year":"2001","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.12968\/hosp.2002.63.3.2060","article-title":"Diagnosis and management of thyroid eye disease","volume":"63","author":"Denniston","year":"2002","journal-title":"Hosp Med"},{"key":"10.1016\/j.ncl.2010.03.010_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/eje.0.1440311","article-title":"Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts","volume":"144","author":"Krassas","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00002341-200211000-00003","article-title":"Current medical management of Graves' ophthalmopathy","volume":"18","author":"Marcocci","year":"2002","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ncl.2010.03.010_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1998.00487.x","article-title":"Current management of thyroid associated ophthalmopathy in Europe. Results of an International Survey","volume":"49","author":"Weetman","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.010_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/eje.0.1480491","article-title":"Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' orbitopathy experience","volume":"148","author":"Prummel","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1210\/jc.77.5.1120","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy","volume":"77","author":"De Carli","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib17","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/275314a0","article-title":"Evidence that the TSH receptor acts as a mitogenic antigen in Graves' disease","volume":"275","author":"Makinen","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2010.03.010_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1993.3.297","article-title":"Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy","volume":"3","author":"Heufelder","year":"1993","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib20","first-page":"279","article-title":"Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts","author":"Bell","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1210\/jcem.82.6.2003","article-title":"Thyrotropin receptor transcripts in human adipose tissue","volume":"82","author":"Crisp","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jc.87.1.385","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/105072502753600133","article-title":"Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy","volume":"12","author":"Smith","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jcem-65-4-665","article-title":"Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy","volume":"65","author":"Bahn","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/thy.1992.2.89","article-title":"Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy","volume":"2","author":"Bahn","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Immunoglobulins from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000236845","article-title":"The fibroblast is the target cell in the connective tissue manifestations of Graves' disease","volume":"106","author":"Bahn","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0161-6420(84)34152-5","article-title":"Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease","volume":"91","author":"Hufnagel","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib29","doi-asserted-by":"crossref","first-page":"22718","DOI":"10.1074\/jbc.271.37.22718","article-title":"Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts","volume":"271","author":"Wang","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2010.03.010_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jcem-72-5-1169","article-title":"Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts","volume":"72","author":"Smith","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib31","doi-asserted-by":"crossref","first-page":"25117","DOI":"10.1074\/jbc.273.39.25117","article-title":"Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes","volume":"273","author":"Spicer","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2010.03.010_bib32","doi-asserted-by":"crossref","first-page":"C382","DOI":"10.1152\/ajpcell.1995.268.2.C382","article-title":"Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts","volume":"268","author":"Smith","year":"1995","journal-title":"Am J Physiol"},{"issue":"6 Pt 1","key":"10.1016\/j.ncl.2010.03.010_bib33","doi-asserted-by":"crossref","first-page":"C1075","DOI":"10.1152\/ajpcell.1999.277.6.C1075","article-title":"Leukoregulin up regulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts","volume":"277","author":"Cao","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib34","first-page":"1018","article-title":"Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts","volume":"38","author":"Muhlberg","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3 Pt 1","key":"10.1016\/j.ncl.2010.03.010_bib35","doi-asserted-by":"crossref","first-page":"C707","DOI":"10.1152\/ajpcell.1998.274.3.C707","article-title":"Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production","volume":"274","author":"Sempowski","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib36","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","volume":"273","author":"Cao","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2010.03.010_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/82725","article-title":"Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins","volume":"1","author":"Stassi","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1999.9.305","article-title":"Dominant infiltration of T (H) 1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy","volume":"9","author":"Yang","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/jc.85.2.776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib40","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1073\/pnas.91.11.5094","article-title":"Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2010.03.010_bib41","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.010_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jc.79.2.542","article-title":"The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole","volume":"79","author":"Kung","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00006231-200111000-00001","article-title":"Radioiodine and Graves' ophthalmopathy reconsidered","volume":"22","author":"Noury","year":"2001","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ncl.2010.03.010_bib44","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00006231-200211000-00016","article-title":"Radioiodine therapy and Graves' ophthalmopathy","volume":"23","author":"Bartalena","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ncl.2010.03.010_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/eje.0.1430155","article-title":"I131 and thyroid-associated ophthalmopathy","volume":"143","author":"Rasmussen","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.010_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1460457","article-title":"Graves' ophthalmology: a preventable disease?","volume":"146","author":"Bartalena","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/acta.0.1290147","article-title":"Graves' ophthalmopathy and tobacco smoking","volume":"129","author":"Tallstedt","year":"1993","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.ncl.2010.03.010_bib49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.269.4.479","article-title":"Smoking and risk of Graves' disease","volume":"260","author":"Prummel","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2010.03.010_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs. lifetime cigarette consumption","volume":"45","author":"Pfelschifter","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders \u2013 a meta-analysis","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.87.6.773","article-title":"Impact of smoking on the response to treatment of thyroid associated ophthalmopathy","volume":"87","author":"Eckstein","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association","volume":"44","author":"Werner","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.010_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.1991.1.357","article-title":"Classification of the eye changes of Graves' disease","volume":"1","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/thy.1998.8.539","article-title":"The measurement of change in Graves' ophthalmopathy","volume":"8","author":"Gorman","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic criteria for Graves' ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2000.00973.x","article-title":"Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.1990.tb00463.x","article-title":"Urinary glycosaminoglycans in Graves' ophthalmopathy","volume":"33","author":"Kahaly","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03344962","article-title":"Plasma glycosaminoglycans in endocrine ophthalmopathy","volume":"17","author":"Kahaly","year":"1994","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.ncl.2010.03.010_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/thy.1998.8.429","article-title":"Hansen glycosaminoglycans in thyroid eye disease","volume":"8","author":"Kahaly","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib64","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2265.2004.02044.x","article-title":"Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy","volume":"60","author":"Martins","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/thy.1995.5.107","article-title":"Role of Octreoscan and correlation with MR imaging in Graves' ophthalmopathy","volume":"5","author":"Kahaly","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib66","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/jc.79.6.1845","article-title":"van der Loos T [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroid and orbital Graves' disease: a parameter for disease activity?","volume":"79","author":"Postema","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0025-6196(12)65533-5","article-title":"Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods","volume":"63","author":"Morris","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2010.03.010_bib68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0025-6196(12)62778-5","article-title":"Assay for thyroid stimulating immunoglobulin","volume":"61","author":"Jiang","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2010.03.010_bib69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotropin receptor antibodies with the clinical features of Graves' ophthalmology","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib70","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/thy.2000.10.809","article-title":"Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease","volume":"10","author":"Noh","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib71","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","article-title":"Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels","volume":"10","author":"Khoo","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib73","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2265.2004.02033.x","article-title":"Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease","volume":"60","author":"Goh","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib74","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2265.2003.01861.x","article-title":"Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy","volume":"59","author":"De Bellis","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1210\/jcem-58-2-332","article-title":"Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin","volume":"58","author":"Rapoport","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib76","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bjo.81.12.1080","article-title":"Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients","volume":"81","author":"Kazuo","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib77","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198212093072407","article-title":"Immunology of autoimmune thyroid diseases","volume":"307","author":"Strakosch","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.010_bib78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1507\/endocrj.42.405","article-title":"Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease","volume":"42","author":"Kashiwai","year":"1995","journal-title":"Endocr J"},{"key":"10.1016\/j.ncl.2010.03.010_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.1977.tb03316.x","article-title":"Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease","volume":"6","author":"Teng","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-48-4-572","article-title":"Changes in thyroid-stimulating immunoglobulins during antithyroid therapy","volume":"48","author":"Fenzi","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jcem-70-1-89","article-title":"Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities","volume":"70","author":"Salvi","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/er.19.6.673","article-title":"The thyrotropin receptor: interaction with thyrotropin and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ncl.2010.03.010_bib83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.1998.8.167","article-title":"Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and non-thyroid diseases","volume":"8","author":"Wu","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib84","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1210\/jc.80.9.2830","article-title":"Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance","volume":"80","author":"Villadolid","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1033001","volume":"157","author":"Hosten","year":"1992","journal-title":"Rofo"},{"key":"10.1016\/j.ncl.2010.03.010_bib86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/105072502753600179","article-title":"Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy","volume":"12","author":"Yokoyama","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2265.2001.01220.x","article-title":"The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy","volume":"54","author":"Prummel","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2010.03.010_bib88","first-page":"61","article-title":"Graves' disease of the orbit","volume":"6","author":"Weber","year":"1996","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.ncl.2010.03.010_bib89","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004170100352","article-title":"MRI measurements of orbital tissues in dysthyroid ophthalmopathy","volume":"239","author":"Nishida","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00004728-200401000-00013","article-title":"Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging","volume":"28","author":"Cakirer","year":"2004","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"Pt 5","key":"10.1016\/j.ncl.2010.03.010_bib91","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/eye.1994.126","article-title":"The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease","volume":"8","author":"Hoh","year":"1994","journal-title":"Eye"},{"key":"10.1016\/j.ncl.2010.03.010_bib92","first-page":"139","article-title":"Graves' ophthalmopathy: usefulness of T2 weighted muscle signal intensity","volume":"84","author":"Sillaire","year":"2003","journal-title":"J\u00a0Radiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib93","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1259\/0007-1285-67-795-244","article-title":"The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease","volume":"67","author":"Laitt","year":"1994","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/eye.2001.102","article-title":"Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease","volume":"15","author":"Mayer","year":"2001","journal-title":"Eye"},{"key":"10.1016\/j.ncl.2010.03.010_bib95","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/thy.1995.5.185","article-title":"MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy","volume":"5","author":"Utech","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib96","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiology.190.3.8115640","article-title":"Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements","volume":"190","author":"Ohnishi","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.ncl.2010.03.010_bib97","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1259\/bjr.75.894.750514","article-title":"Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?","volume":"75","author":"Ott","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib98","first-page":"143","volume":"68","author":"Sato","year":"1992","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"key":"10.1016\/j.ncl.2010.03.010_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/thy.1992.2.299","article-title":"Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy","volume":"2","author":"Hiromatsu","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(93)31607-6","article-title":"A\u00a0new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy","volume":"100","author":"Prummel","year":"1993","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.010_bib101","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/eje.0.1400373","article-title":"The role of Octreoscan in thyroid eye disease","volume":"140","author":"Krassas","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/105072502753600188","article-title":"Octreoscan in thyroid associated ophthalmopathy","volume":"12","author":"Krassas","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ncl.2010.03.010_bib103","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jcem-55-3-434","article-title":"Characterization of the somatomedin C\/insulin like growth factor I (SM-C\/IGF-I) receptor on cultured human fibroblast monolayers. Regulation of receptor concentrations by SM-C\/IGF-I and insulin","volume":"55","author":"Rosenfeld","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib104","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1016\/S0021-9258(17)44530-3","article-title":"Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor","volume":"258","author":"Jacobs","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2010.03.010_bib105","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/MCB.17.3.1084","article-title":"The insulin like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin 3 withdrawal","volume":"17","author":"Prisco","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib106","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.4049\/jimmunol.163.6.3123","article-title":"Reciprocal desensitization fo CCR5 and CD4 is mediated by IL-16 and macrophage-inflammatory protein-1 beta, respectively","volume":"163","author":"Mashikian","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib107","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/PL00000744","article-title":"Structure and function of the type 1 insulin-like growth factor receptor","volume":"57","author":"Adams","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ncl.2010.03.010_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J","article-title":"Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis","volume":"183","author":"Grimberg","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/0470869976.ch10","article-title":"Structural biology of insulin and IGF-1 receptors","volume":"262","author":"De Meyts","year":"2004","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.ncl.2010.03.010_bib110","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib111","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","article-title":"Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone","volume":"56","author":"Bartalena","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib112","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.010_bib113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/thy.1997.7.579","article-title":"Intravenous immunoglobulin vs. corticosteroids in treatment of Graves' ophthalmopathy","volume":"7","author":"Baschieri","year":"1997","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.ncl.2010.03.010_bib114","first-page":"833","article-title":"Therapeutic responses to corticosteroids in Graves' ophthalmopathy","volume":"95","author":"Chang","year":"1996","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0420.1997.tb00779.x","article-title":"Relationships of orbital computed tomography and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy","volume":"75","author":"Chang","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"6676","key":"10.1016\/j.ncl.2010.03.010_bib116","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.298.6676.830","article-title":"Methylprednisolone and Graves' ophthalmopathy","volume":"298","author":"Dandona","year":"1989","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ncl.2010.03.010_bib117","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","article-title":"Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone","volume":"88","author":"Ebner","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib118","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0161-6420(89)32784-9","article-title":"Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy","volume":"96","author":"Guy","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1507\/endocrj.40.63","article-title":"Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy","volume":"40","author":"Hiromatsu","year":"1993","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1034\/j.1600-0420.2002.800316.x","article-title":"High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy","volume":"80","author":"Kauppinen-Makelin","year":"2002","journal-title":"Acta ophthalmol Scand"},{"issue":"9","key":"10.1016\/j.ncl.2010.03.010_bib121","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(91)32114-6","article-title":"Treatment of acute Graves' orbitopathy","volume":"98","author":"Kazim","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib122","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.297.6663.1574","article-title":"Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy","volume":"297","author":"Kendall-Taylor","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.ncl.2010.03.010_bib123","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/thy.1994.4.409","article-title":"Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation","volume":"4","author":"Koshiyama","year":"1994","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib124","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-978843","article-title":"Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy","volume":"30","author":"Matejka","year":"1998","journal-title":"Horm Metab Res"},{"issue":"41\u201342","key":"10.1016\/j.ncl.2010.03.010_bib125","first-page":"603","article-title":"Graves' ophthalmopathy: natural history and treatment outcomes","volume":"131","author":"Noth","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ncl.2010.03.010_bib126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/acta.0.1160513","article-title":"Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy","volume":"116","author":"Nagayama","year":"1987","journal-title":"Acta Endocrinol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib127","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiology.196.3.7644656","article-title":"Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids","volume":"196","author":"Nakahara","year":"1995","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(02)01970-0","article-title":"Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy","volume":"135","author":"Ohtsuka","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000425706","article-title":"Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease)","volume":"30","author":"Staar","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.ncl.2010.03.010_bib130","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","article-title":"Prednisolone and cyclosporine in the treatment of severe Graves' ophthalmopathy","volume":"321","author":"Prummel","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/08820539909056064","article-title":"Thyroid eye disease","volume":"14","author":"Scott","year":"1999","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib132","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1507\/endocrj.43.689","article-title":"High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy","volume":"43","author":"Tagami","year":"1996","journal-title":"Endocr J"},{"key":"10.1016\/j.ncl.2010.03.010_bib133","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNO.0b013e31814a5ef8","article-title":"Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease","volume":"27","author":"Zoumalan","year":"2007","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib134","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00002341-200205000-00002","article-title":"Perspective\u2013Part I: the Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) study: lessons learned","volume":"18","author":"Bartley","year":"2002","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ncl.2010.03.010_bib135","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves' orbitopathy: randomized placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2010.03.010_bib136","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A\u00a0prospective, randomized, double blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A\u00a0randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib138","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1365-2265.2002.01525.x","article-title":"Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?","volume":"56","author":"Perros","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib139","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.86.1.102","article-title":"Does radiotherapy have a role in the management of thyroid orbitopathy?","volume":"86","author":"Cockerham","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bjo.86.1.102","article-title":"Does radiotherapy have a role in the management of thyroid orbitopathy? Comment","volume":"86","author":"McNab","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ncl.2010.03.010_bib141","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0161-6420(01)00729-1","article-title":"Radiation therapy for Graves' ophthalmopathy: trick or treat?","volume":"108","author":"Feldon","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib142","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0161-6420(02)01848-1","article-title":"Orbital radiation therapy for Graves' ophthalmopathy","volume":"110","author":"Bartalena","year":"2003","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib143","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0161-6420(02)01844-4","article-title":"Orbital radiation therapy for Graves' ophthalmology","volume":"110","author":"Meyer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib144","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0161-6420(02)01840-7","article-title":"Orbital radiation therapy for Graves' ophthalmology","volume":"110","author":"Ainbinder","year":"2003","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.010_bib145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0360-3016(98)00405-2","article-title":"Place of radiotherapy in the treatment of Graves' orbitopathy","volume":"43","author":"Beckendorf","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Pt 5","key":"10.1016\/j.ncl.2010.03.010_bib146","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/eye.1997.183","article-title":"Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease","volume":"11","author":"Claridge","year":"1997","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib147","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves' ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib148","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0360-3016(94)00364-Q","article-title":"Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy","volume":"31","author":"Erickson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib149","first-page":"71","article-title":"Radiotherapy in thyroid eye disease: the effect on the field of binocular single vision","volume":"6","author":"Ferris","year":"2002","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ncl.2010.03.010_bib150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000425705","article-title":"Clinical importance of radiotherapy in the treatment of Graves' disease","volume":"30","author":"Friedrich","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib151","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)03795-1","article-title":"Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy","volume":"55","author":"Jing","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ncl.2010.03.010_bib152","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0161-6420(02)01293-9","article-title":"The aftermath of orbital radiotherapy for Graves' ophthalmopathy","volume":"109","author":"Gorman","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib153","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/105072502753600232","article-title":"Radiotherapy for Graves' ophthalmopathy: results at one year","volume":"12","author":"Gorman","year":"2002","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib154","first-page":"94","article-title":"Hypofractionated radiotherapy for Graves' orbitopathy","volume":"54","author":"Heyd","year":"2001","journal-title":"Rontgenpraxis"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0002-9394(14)76027-1","article-title":"Radiation therapy for thyroid eye diseases","volume":"99","author":"Hurbli","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib156","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1148\/radiology.179.1.2006276","article-title":"Graves's ophthalmopathy: role of MR imaging in radiation therapy","volume":"179","author":"Just","year":"1991","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/jc.85.1.102","article-title":"Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial","volume":"85","author":"Kahaly","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib158","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archopht.1993.01090060107032","article-title":"Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes","volume":"111","author":"Kao","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.010_bib159","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(14)76158-6","article-title":"Supervoltage orbital radiotherapy in 36 cases of Graves' disease","volume":"113","author":"Lloyd","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.010_bib160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib161","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","article-title":"Long-term results of irradiation for patients with progressive Graves' ophthalmopathy","volume":"51","author":"Marquez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ncl.2010.03.010_bib162","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/0360-3016(85)90088-4","article-title":"Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results","volume":"11","author":"Olivotto","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ncl.2010.03.010_bib163","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/0360-3016(87)90346-4","article-title":"Radiation therapy for Graves' ophthalmopathy: a retrospective analysis","volume":"13","author":"Palmer","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib164","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(90)90532-O","article-title":"Prognostic factors in the radiotherapy of Graves' ophthalmopathy","volume":"19","author":"Petersen","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ncl.2010.03.010_bib165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000180697","article-title":"High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy","volume":"26","author":"Pigeon","year":"1987","journal-title":"Horm Res"},{"issue":"8877","key":"10.1016\/j.ncl.2010.03.010_bib166","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.010_bib167","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/jjco\/28.6.364","article-title":"Radiotherapy in the management of Graves' ophthalmopathy","volume":"28","author":"Sakata","year":"1998","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.010_bib168","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0360-3016(89)90073-4","article-title":"Results of radiotherapy for thyroid ophthalmopathy","volume":"17","author":"Sandler","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ncl.2010.03.010_bib169","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000425707","article-title":"Radiotherapy for severe, progressive thyroid-associated ophthalmopathy: long-term results with comparison of scoring systems","volume":"30","author":"Seegenschmiedt","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.ncl.2010.03.010_bib170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0161-6420(02)01846-8","article-title":"Orbital radiation therapy for Graves' ophthalmology","volume":"110","author":"Steinsapir","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib171","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1980.tb03422.x","article-title":"An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy","volume":"13","author":"Teng","year":"1980","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib172","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03348485","article-title":"Radiotherapy of severe ophthalmic Graves' disease","volume":"8","author":"van Ouwerkerk","year":"1985","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.010_bib173","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000309924","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.ncl.2010.03.010_bib174","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/archopht.1995.01100110080029","article-title":"Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance","volume":"113","author":"Wilson","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ncl.2010.03.010_bib175","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/jc.2009-0376","article-title":"Treatment modalities for Graves' ophthalmopathy: systemic review and metaanalysis","volume":"94","author":"Stiebel-Kalish","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ncl.2010.03.010_bib176","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","article-title":"Rituximab Treatment of patients with severe, corticosteroid resistant thyroid associated ophthalmopathy","volume":"117","author":"Khanna","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.010_bib177","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/eje.1.02140","article-title":"The rationale for B lymphocyte depletion in Graves' disease: monoclonal anti-CD20 antibody therapy as a novel treatment option","volume":"154","author":"El Fassi","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib178","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2008.09.007","article-title":"Treatment of Graves' disease with Rituximab specifically reduces the production of thyroid stimulating autoantibodies","volume":"130","author":"El Fassi","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ncl.2010.03.010_bib179","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archopht.116.2.227","article-title":"Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib181","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ)","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib182","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(02)01337-5","article-title":"Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire","volume":"133","author":"Ma","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2010.03.010_bib183","first-page":"A37","article-title":"Validation of a 10-Item Neuro-Ophthalmic Supplement to the VFQ-25","volume":"64","author":"Raphael","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2010.03.010_bib184","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0895-4356(99)00069-4","article-title":"Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy","volume":"52","author":"Terwee","year":"1999","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ncl.2010.03.010_bib185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/eje.0.1460751","article-title":"Long-term effects of Graves' ophthalmopathy on health-related quality of life","volume":"146","author":"Terwee","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib186","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.010_bib187","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/112067210401400302","article-title":"Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy","volume":"14","author":"Tehrain","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib188","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjo.88.1.75","article-title":"Assessing quality of life in Australian patients with Graves' ophthalmopathy","volume":"99","author":"Park","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.010_bib189","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01241.x","article-title":"Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments","volume":"54","author":"Terwee","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ncl.2010.03.010_bib190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/eje.0.1510549","article-title":"Impaired health-related quality of life in Graves' disease. A prospective study","volume":"151","author":"Eberling","year":"2004","journal-title":"Euro J of Endocrinol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:50:18Z","timestamp":1711626618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861910000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":190,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0733861910000484"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2010.03.010","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}